InvestorsHub Logo
icon url

Jerry70

11/21/13 1:57 PM

#9074 RE: appalled #9073

You can not sell the 10 Million shares Twice. Now if they sold them for $1,800,000 as suggested that would end it, but i dont think that was the case. FINRA & Lawyers are working on that according to Jacobs PR. Guess we will see at some point & time IMO. SAFC
icon url

Jerry70

11/21/13 2:09 PM

#9075 RE: appalled #9073

That is your thoughts, but there is nothing to back up those thoughts and those 10 Million shares were only free to trade after the Agreement November 15th dead line accrording to the Filings but that is between FINRA & Lawyers IMO and according to what the PR Jacob put out but we all know you cant pay alot of attention to any PR Jacob put out for 2 years now JMO. SAFC
icon url

Jerry70

11/21/13 2:33 PM

#9078 RE: appalled #9073

Appalled. This is not a PR. But SEC Filings and Jacob tryed every thing in the book to try and get around this and changed his deal several different times to try and avoid paying the shareholders as everyone knows so its up to Jacob & the SEC to get this worked out IMO. I Am all for the Shareholders and hope they get thier Dividen!!

Medisafe 1 Technologies Reiterates Intention to Issue a Special Dividend of $0.01 (one cent) for Each Share of Common Stock
Print
Alert
Medisafe 1 Technologies Corp. (OTCBB:MFTHE)
Historical Stock Chart

2 Years : From Nov 2011 to Nov 2013
Click Here for more Medisafe 1 Technologies Corp. Charts.

JERUSALEM, September 24, 2012 /PRNewswire/ --

?Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today once again that the company intends to issue a one-time special dividend to all existing shareholders pending the perpetual license sale of technology rights to a third party.

As recently reported, Medisafe 1 Technologies expects to close a $7MM non-exclusive perpetual license sale in early to mid-October. The agreement will transfer rights for the full commercialization, marketing and distribution of its patented medicinal locking mechanism and bar-code matching system to a third party.

Terms of the sale include a one-time $7MM payment. As a reward to Medisafe 1 Technologies' shareholders, the company then intends to issue a one-time dividend of $0.01 per share to each shareholder, approximately $5MM.

Currently, the company has approximately 500MM shares outstanding. As such, the company intends to payout approximately $5MM to shareholders in dividends upon successful completion of the sale.

"As a gesture to our investors, we will be extremely pleased to issue this special dividend pending the closure of our perpetual license sale agreement," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp.